Scholtz & Company’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-40,105
| Closed | -$7.29M | – | 77 |
|
|
2021
Q1 | $7.29M | Buy |
40,105
+760
| +2% | +$138K | 2.77% | 8 |
|
|
2020
Q4 | $7.87M | Buy |
39,345
+2,866
| +8% | +$573K | 3.07% | 9 |
|
|
2020
Q3 | $8M | Buy |
36,479
+159
| +0.4% | +$34.9K | 3.49% | 8 |
|
|
2020
Q2 | $6.93M | Sell |
36,320
-5,705
| -14% | -$1.09M | 3.46% | 8 |
|
|
2020
Q1 | $6.51M | Sell |
42,025
-552
| -1% | -$85.6K | 4.99% | 6 |
|
|
2019
Q4 | $3.57M | Buy |
42,577
+325
| +0.8% | +$27.2K | 2.07% | 20 |
|
|
2019
Q3 | $2.86M | Buy |
42,252
+5,820
| +16% | +$394K | 1.91% | 17 |
|
|
2019
Q2 | $2.42M | Buy |
36,432
+4,717
| +15% | +$313K | 1.57% | 28 |
|
|
2019
Q1 | $1.76M | Buy |
+31,715
| New | +$1.76M | 1.18% | 30 |
|
|
2018
Q4 | – | Sell |
-35,735
| Closed | -$3.09M | – | 60 |
|
|
2018
Q3 | $3.09M | Buy |
35,735
+17,934
| +101% | +$1.55M | 1.95% | 21 |
|
|
2018
Q2 | $1.03M | Buy |
+17,801
| New | +$1.03M | 0.72% | 32 |
|